VirtualScopics and PPD
Partnering to Advance Oncology Clinical Trials
VirtualScopics and PPD, two of the leaders in oncology clinical research, have established an exclusive alliance that provides clients with strategically integrated and customized clinical development and medical imaging services for oncology clinical trials. The VirtualScopics/PPD strategic alliance expedites clients' oncology clinical trials with a best-in-class, comprehensive offering that will help clients gain efficiencies in time and cost; make fast, confident go/no go decisions in early phase research; or determine study endpoints quickly in later phases.
Single Source Solution
The seamless integration of services between the two companies will establish a more efficient, tailored approach across several key areas of the clinical trial process including study start-up, screening and enrollment, protocol implementation, accurate determination and collection of endpoints related to radiographic response and progression, management of imaging data and proactive risk management.
- Tailored solutions designed to meet the unique needs of each client's oncology development program and quickly progress their therapies from early phase to regulatory approval.
- Streamlined access to PPD's global oncology expertise and VirtualScopics' advanced imaging processes and technologies.
- Global oncology study support with combined offices in 42 countries and experience training and managing over 4000 imaging sites across 45 countries.